12/08/2025
We support the statement of the American Academy of Pediatrics and more than 40 other leading health organizations that "the hepatitis B birth dose is safe and an essential component in helping children develop immunity against a serious, potentially lifelong disease."
A statement from more than 40 leading medical, health and patient advocacy organizations in response to this week’s ACIP meeting:
"We are deeply alarmed by the actions taken this week by the Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices (ACIP). The apparent goal of this meeting was to sow doubt in vaccines rather than advance sound vaccine policy, and we will all pay a price for that.
This is a significant departure from the historic role ACIP has played in shaping vaccine policy in the United States. Previously, we could expect science to drive decisions, experts to debate evidence, and consensus to lead to shared, clear recommendations. That is not the case with the current committee, and this change puts Americans’ health at risk.
The evidence remains clear: the hepatitis B birth dose is safe and an essential component in helping children develop immunity against a serious, potentially lifelong disease. In fact, since the U.S. implemented the hepatitis B birth dose in 1991, annual hepatitis B infections among infants and children have dropped 99%, from 16,000 to less than 20. This progress is directly attributable to timely vaccination.
ACIP’s actions will harm children, their families and the medical professionals who care for them. That is why we are joining together to speak up. American families deserve information grounded in science and clear, consistent guidance – not speculation intended to scare them. We urge the CDC leaders to reject ACIP’s new recommendation and instead retain the current, evidence-based approach.”
Read the full statement: https://bit.ly/4a0EyFN
